The Medical Readiness Contracting Office – Pacific intends to issue a bulk-funded BPA call to Abbott Laboratories Inc. for Clinical Chemistry and Immunoassay reagents for December 2023 and January 2024 for Tripler Army Medical Center, Hawaii. The statutory authority permitting this award without providing full and open competition is FAR 13.106-1(b)(1)(i), which authorizes the Government to award contracts when the circumstances of the contract action deem only one reasonably available and no other suppliers or services will satisfy agency requirements. This announcement fulfills the synopsis requirement under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government.

Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organizations qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.

Attachments/Links